Clinical trial
Memantine Treatment for Improving Rehabilitation Outcomes and Preventing…
NCT00183729 · Eric Lenze, Other · Completed
Key facts
| NCT number | NCT00183729 |
|---|---|
| Title | Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults |
| Official title | Memantine for Enhancement of Rehabilitation Efficacy and Prevention of Major Depressive Disorder in Older Adults |
| Lead sponsor | Eric Lenze, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug, Other |
| Interventions | Memantine, Placebo |
| Enrollment | 35 |
| Start date | Aug 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 17, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: